Cargando…

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and economic damage worldwide and effective drugs that prevent or cure COVID-19 are urgently needed. Approved drugs including Hydroxychloroquine, Remdesivir or Interferon were reported to inhibit the infection or propagati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shionoya, Kaho, Yamasaki, Masako, Iwanami, Shoya, Ito, Yusuke, Fukushi, Shuetsu, Ohashi, Hirofumi, Saso, Wakana, Tanaka, Tomohiro, Aoki, Shin, Kuramochi, Kouji, Iwami, Shingo, Takahashi, Yoshimasa, Suzuki, Tadaki, Muramatsu, Masamichi, Takeda, Makoto, Wakita, Takaji, Watashi, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119653/ https://www.ncbi.nlm.nih.gov/pubmed/33995308 http://dx.doi.org/10.3389/fmicb.2021.651403

Ejemplares similares

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma
por: Iwanami, Shoya, et al.
Publicado: (2020)

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments
por: Akazawa, Daisuke, et al.
Publicado: (2023)

Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2
por: Saso, Wakana, et al.
Publicado: (2022)

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
por: Ohashi, Hirofumi, et al.
Publicado: (2022)

Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses
por: Kobayashi, Chisa, et al.
Publicado: (2022)

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
por: Watashi, Koichi, et al.
Publicado: (2014)

Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019)

Revisiting the guidelines for ending isolation for COVID-19 patients
por: Jeong, Yong Dam, et al.
Publicado: (2021)

Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model
por: Ejima, Keisuke, et al.
Publicado: (2021)

Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors
por: Tatematsu, Daiki, et al.
Publicado: (2023)

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide
por: Kaneko, Manabu, et al.
Publicado: (2018)

Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives
por: Nishiuchi, Kota, et al.
Publicado: (2021)

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus
por: Kitamura, Kouichi, et al.
Publicado: (2018)

Estimation of the incubation period of COVID-19 using viral load data
por: Ejima, Keisuke, et al.
Publicado: (2021)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
por: Iwanami, Shoya, et al.
Publicado: (2021)

High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon
por: Matsuda, Mami, et al.
Publicado: (2018)

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers
por: Kikuchi, Minami, et al.
Publicado: (2021)

Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis
por: Rufener, Reto, et al.
Publicado: (2018)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
por: Watashi, Koichi, et al.
Publicado: (2013)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture
por: Iwanami, Shoya, et al.
Publicado: (2017)

Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents
por: Hishiki, Takayuki, et al.
Publicado: (2023)

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria
por: Gutman, Julie, et al.
Publicado: (2009)

Mefloquine: Psychosis: case report
Publicado: (2022)

Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system
por: Suda, Yuto, et al.
Publicado: (2016)

Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2
por: Suzuki, Ryosuke, et al.
Publicado: (2013)

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
por: Shimura, Satomi, et al.
Publicado: (2017)

The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro
por: Gad, Sameh A., et al.
Publicado: (2022)

Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2009)

Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria
por: Saeheng, Teerachat, et al.
Publicado: (2023)

Hepatitis B Virus Genotype-Dependent Vulnerability of Infected Cells to Immune Reaction in the Early Phase of Infection
por: Shiina, Masaaki, et al.
Publicado: (2019)

Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells
por: Yamada, Souichi, et al.
Publicado: (2021)

Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018)

Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3o4kg6qr9celhn8cljsk19700o